# ALLYRNA

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/allyrna

- Industry: Pharmaceuticals
- Headquarters: Hong Kong, Hong Kong SAR - China
- Total disclosed funding: $10M
- Latest round: Seed (Aug 27, 2026)
- Investors on record: 8

## About

Based in Hong Kong, China and founded in 2025 by He Chuan, ALLYRNA (Hong Kong) Co., Ltd., trading as ALLYRNA, was established by Professor He Chuan of the University of Chicago, an expert in RNA epigenetics and recipient of the Wolf Prize in Chemistry. The company’s development strategy centers on drug innovation, aiming to address unmet needs in cancer treatment. 
In August 2026, ALLYRNA raised a Seed+ funding co-led by Shanghai State-owned Capital Investment Leading Fund, Shanghai Engine Fund, TTM Capital, with participation from Casstar Capital, returning investors Gaorong Ventures, Plaisance Capital.
ALLYRNA is building a technology platform focused on sensitizers for radiotherapy and immunotherapy. The company's pipeline emphasizes first-in-class small molecule drugs that enhance therapeutic responses in oncology, with applications in tumor treatment and potentially other related disease areas.
As a research-driven biotechnology company, ALLYRNA is currently in the development stage. Future revenue is expected to derive from licensing of intellectual property, partnerships with pharmaceutical companies, and eventual commercialization of its proprietary drug candidates.
ALLYRNA will continue to advance its core R&D projects and optimize its drug candidates, improve its preclinical development system and global intellectual property layout, further strengthen its core talent team, and accelerate the translation of globally competitive original scientific research results into innovative drugs.

## Funding rounds

- Seed, Aug 27, 2026 — Plaisance Capital, Gaorong Ventures, Casstar Capital, TTM Capital, Shanghai State-owned Capital Investment Leading Fund, Shanghai Engine Fund
- Seed, Aug 24, 2025, $10M — Plaisance Capital, Gaorong Ventures, Jifeng Ventures, Together To Miracle

## Investors

- Plaisance Capital — Seed
- Gaorong Ventures (https://capitalatlas.ai/funds/gaorong-ventures) — Seed
- Jifeng Ventures (https://capitalatlas.ai/funds/jifeng-ventures) — Seed
- Together To Miracle — Seed
- Casstar Capital (https://capitalatlas.ai/funds/casstar-capital) — Seed
- TTM Capital (https://capitalatlas.ai/funds/ttm-capital) — Seed
- Shanghai State-owned Capital Investment Leading Fund (https://capitalatlas.ai/funds/shanghai-state-owned-capital-investment-leading-fund) — Seed
- Shanghai Engine Fund (https://capitalatlas.ai/funds/shanghai-engine-fund) — Seed